Legend:
CC = Colorado Convention Center H = Hyatt Regency Denver at Colorado Convention Center
* = applied session ! = JSM meeting theme
Activity Details
|
|
|
|
9 * !
|
Sun, 7/28/2019,
2:00 PM -
3:50 PM
|
CC-111
|
|
Impact of Using Surrogate Endpoints on Drug Development — Invited Papers
|
|
WNAR, International Chinese Statistical Association, Biopharmaceutical Section
|
|
Organizer(s): Ying Lu, Stanford University
|
|
Chair(s): Ying Zhang, University of Nebraska Medical Center
|
|
2:05 PM
|
Havrda and Charvat Entropy-Based Measures to Assess Longitudinal Surrogate Endpoints in Clinical Trials
María del Carmen Pardo , Complutense University; Ying Lu, Stanford University; Hua Jin, South China Normal University; Qian Zhao, Guangzhou Medical University
|
|
2:25 PM
|
Statistical Considerations for Biomarker-Based Surrogate Endpoints
Marc Buyse, IDDI Inc.
|
|
2:45 PM
|
An Information-Theoretic Approach for the Evaluation of Surrogate Endpoints Based on Causal Inference
Ariel Alonso Abad, KUleuven
|
|
3:05 PM
|
Model Free Approach to Quantifying the Proportion of Treatment Effect Explained by a Surrogate Marker
Lu Tian, Stanford University School of Medicine; Tianxi Cai, Harvard University ; Xuan Wang, Harvard University; Layla Parast, RAND
|
|
3:25 PM
|
Discussant: Ying Lu, Stanford University
|
|
3:45 PM
|
Floor Discussion
|
|
